Tractus Vascular receives 510(k) clearance for its TractusTM CSC
Category: #health  By Mateen Dalal  Date: 2019-11-04
  • share
  • Twitter
  • Facebook
  • LinkedIn

Tractus Vascular receives 510(k) clearance for its TractusTM CSC

Vascular diseases are commonly termed as any abnormal condition that arises in the blood vessels (veins and arteries) which can lead to severe disability or death. Currently, there are several treatment alternatives for this condition, but several pharma companies are still searching for novel breakthroughs for treating this condition. 

Tractus Vascular LLC recently made some strides when it announced receiving a 510(k) clearance for its TractusTM Crossing Support Catheter (CSC) with lengths of 170 cm, 155 cm, 135 cm and 90 cm and with 0.035”, 0.018” and 0.014” guidewire compatibility.

For the record, TractusTM CSC is a highly novel treatment for vascular disease and is built for the purpose of using it during interventional procedures in the coronary and peripheral vasculature to maintain a guidewire as well as access in discrete regions, offer a channel for delivering contrast media and saline solutions, and permit guidewire exchanges.

Moreover, with most CSC being built with a braided sheath, Tractus provides its Jigsaw TechnologyTM laser cut stainless-steel shaft that includes a continuous helical cut pattern developing interlocking teeth.

Speaking on the clearance, Janet Burpee, Chairman and CEO/CTO, Tractus said that obtaining the FDA’s approval marks as one of many milestones in developing market technology that leverages economies in current catheter laboratories while always concentrating on user needs and patient outcomes.

Reportedly, Tractus Vascular was earlier built from an incubator firm, Tinker Med, LLC, which was originally a fully owned subsidiary of Burpee MedSystems, LLC. Commenting on this, Burpee said that, with Burpee MedSystems’ sale, Tinker Med could concentrate more on its firms that include Venarum Medical and Tractus Vascular.

Incidentally, medical device company Medtronic plc has also made significant development in the field of vascular disease when it revealed that it has obtained Breakthrough Device designation for its Valiant® TAAA Stent Graft System from the U.S. FDA. 

Reportedly, the platform is used for repair of TAAA (thoracoabdominal aortic aneurysm), a complex issue that causes bloating of the aorta, that spreads from the chest to the abdomen, with minimally invasion.

Source Credit: https://www.businesswire.com/news/home/20191102005020/en/Tractus-Crossing-Support-Catheter-Jigsaw-TechnologyTM-Receives

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

PayPal buys Happy Returns to strengthen reverse logistics system
PayPal buys Happy Returns to strengthen reverse logistics system
By Mateen Dalal

U.S. based digital payments platform, PayPal, an online payment system entity has announced the purchase of Happy Returns- a returns solution firm that provides online buyers access to simplified ways to return unwanted merchandise to retailers; elim...

YOP officially unveils YOP app to ease access to DeFi for the masses
YOP officially unveils YOP app to ease access to DeFi for the masses
By Mateen Dalal

Yield Optimization Platform and Protocol (YOP) recently declared its official launch of YOP application; the first all-in-one mobile app which makes it quite easier for everyone to access DeFi. The V0 version of the app is now available for early acc...

Singapore to create second national supercomputer with more on roadmap
Singapore to create second national supercomputer with more on roadmap
By Mateen Dalal

Following its success of the first supercomputer system, Singapore is set to build its upcoming second supercomputer system in an attempt to strengthen the local research community, offering 8X more computing capacity than its previous model. The sy...